We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $463M
1-Year Est. Return 16%
This Fund
S&P 500
This Quarter Est. Return
+0.56%
1 Year Est. Return
+16%
3 Year Est. Return
+35.45%
5 Year Est. Return
+32.62%
10 Year Est. Return
+255.18%
AUM
$463M
AUM Growth
+$48.8M
Cap. Flow
+$67.4M
Cap. Flow %
14.57%
Top 10 Hldgs %
9.27%
Holding
349
New
97
Increased
39
Reduced
45
Closed
81

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$4.67M
2
CHTR icon
Charter Communications
CHTR
+$3.95M
3
G icon
Genpact
G
+$3.93M
4
PCRX icon
Pacira BioSciences
PCRX
+$3.26M
5
ALKS icon
Alkermes
ALKS
+$2.94M

Sector Composition

Rank Sector Weight
1 Healthcare 22.45%
2 Technology 18.35%
3 Consumer Discretionary 17.18%
4 Consumer Staples 10.71%
5 Financials 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CORT icon
1
Corcept Therapeutics
CORT
$10.2B
$5.08M 1.1%
126,000
+94,500
+300% +$3.53M
UNFI icon
2
United Natural Foods
UNFI
$3.03B
$4.73M 1.02%
105,000
-21,000
-17% -$804K
CPB icon
3
Campbell Soup
CPB
$6.63B
$4.68M 1.01%
210,000
+105,000
+100% +$2.7M
APA icon
4
APA Corp
APA
$12.6B
$4.46M 0.96%
105,000
ETSY icon
5
Etsy
ETSY
$7.79B
$4.2M 0.91%
84,000
ANIP icon
6
ANI Pharmaceuticals
ANIP
$1.77B
$4.04M 0.87%
52,500
+21,000
+67% +$1.64M
CNXC icon
7
Concentrix
CNXC
$1.45B
$4.02M 0.87%
147,000
+63,000
+75% +$2.24M
SEZL
8
Sezzle
SEZL
$5.92B
$3.99M 0.86%
63,000
+10,500
+20% +$715K
ULTA icon
9
Ulta Beauty
ULTA
$21.2B
$3.84M 0.83%
+7,350
New +$4.68M
PSIX
10
Power Solutions International
PSIX
$729M
$3.84M 0.83%
63,000
+31,500
+100% +$2.25M
DG icon
11
Dollar General
DG
$27.3B
$3.74M 0.81%
31,500
+21,000
+200% +$2.99M
ACAD icon
12
Acadia Pharmaceuticals
ACAD
$4.33B
$3.74M 0.81%
168,000
+21,000
+14% +$502K
QLYS icon
13
Qualys
QLYS
$5.01B
$3.69M 0.8%
42,000
+25,200
+150% +$2.79M
PGNY icon
14
Progyny
PGNY
$2.49B
$3.57M 0.77%
210,000
+84,000
+67% +$1.8M
AEO icon
15
American Eagle Outfitters
AEO
$2.91B
$3.51M 0.76%
+210,000
New +$4.72M
COLL icon
16
Collegium Pharmaceutical
COLL
$1.17B
$3.47M 0.75%
+105,000
New +$4.45M
IRTC icon
17
iRhythm Holdings
IRTC
$3.62B
$3.47M 0.75%
29,400
+14,700
+100% +$2.12M
INVA icon
18
Innoviva
INVA
$1.59B
$3.43M 0.74%
147,000
+42,000
+40% +$905K
HALO icon
19
Halozyme
HALO
$9.27B
$3.39M 0.73%
52,500
VSAT icon
20
Viasat
VSAT
$9.98B
$3.37M 0.73%
73,500
-10,500
-13% -$472K
QGEN icon
21
Qiagen
QGEN
$8.31B
$3.36M 0.73%
+84,000
New +$3.98M
TLN
22
Talen Energy Corp
TLN
$17.8B
$3.35M 0.72%
10,500
+6,300
+150% +$2.22M
UI icon
23
Ubiquiti
UI
$32.1B
$3.32M 0.72%
4,200
-4,200
-50% -$2.85M
SEDG icon
24
SolarEdge
SEDG
$3.07B
$3.22M 0.7%
63,000
-10,500
-14% -$395K
AMRC icon
25
Ameresco
AMRC
$1.24B
$3.21M 0.69%
+126,000
New +$3.78M

Similar funds

Hussman Strategic Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Hussman Strategic Advisors held 349 positions worth $463M, up 12% from $414M the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Hussman Strategic Advisors deployed $67.4M of net new capital in Q1 2026, opening 97 new positions and adding to 39 existing holdings. Its largest new stake was American Eagle Outfitters: 210,000 shares worth $3.51M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Ubiquiti, an estimated $2.85M trimmed.

  • Hussman Strategic Advisors's largest Q1 2026 buy was American Eagle Outfitters: 210,000 shares worth $3.51M.
  • Hussman Strategic Advisors added most to Corcept Therapeutics in Q1 2026, an estimated $3.53M increase.
  • Hussman Strategic Advisors's biggest Q1 2026 reduction was Ubiquiti, cutting an estimated $2.85M.
  • Hussman Strategic Advisors fully exited Qualcomm in Q1 2026, selling an estimated $4.67M.
  • Hussman Strategic Advisors's ten largest holdings make up 9.3% of its $463M portfolio in Q1 2026.
  • Hussman Strategic Advisors opened 97 new positions and closed 81 in Q1 2026.
  • Hussman Strategic Advisors's portfolio value rose 12% quarter-over-quarter to $463M.

Based on Hussman Strategic Advisors's 13F filing for Q1 2026, filed 11 May 2026.